topical interferon Alpha-2b

Helix BioPharma Corp. Provides Update on Phase II/III IND Application for Topical Interferon Alpha-2b
MarketWatch
Sat, 11/20/10 - 12:46 pm
Helix BioPharma
topical interferon Alpha-2b
cervical lesions
cervical cancer